China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. (SHE: 000999)

Market Cap	58.31B
Revenue (ttm)	25.70B
Net Income (ttm)	3.37B
Shares Out	1.28B
EPS (ttm)	2.63
PE Ratio	17.24
Forward PE	17.31
Dividend	1.15 (2.54%)
Ex-Dividend Date	Jun 14, 2024

Volume	5,304,643
Open	46.12
Previous Close	45.40
Day's Range	44.65 - 46.12
52-Week Range	31.17 - 50.65
Beta	0.37
Analysts	n/a
Price Target	n/a
Earnings Date	Oct 28, 2024

About China Resources Sanjiu Medical & Pharmaceutical

China Resources Sanjiu Medical & Pharmaceutical Co., Ltd. engages in the research and development, production, and sale of pharmaceutical products in the People’s Republic of China and internationally. The company offers health consumer products (CHC), including cold, skin, gastrointestinal, cough, orthopedics, pediatrics drugs, and dietary nutritional supplements; and prescription drug products, such as anti-tumor, cardiovascular and cerebrovascular, digestive system, orthopedics, pediatrics, and other treatment areas; Chinese medicine injecti...

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 1999
• Employees: 20,318
• Stock Exchange: Shenzhen Stock Exchange
• Ticker Symbol: 000999

Financial Performance

In 2023, China Resources Sanjiu Medical & Pharmaceutical's revenue was 24.74 billion, an increase of 36.83% compared to the previous year's 18.08 billion. Earnings were 2.85 billion, an increase of 16.50%.